MRTF-A controls vessel growth and maturation by increasing the expression of CCN1 and CCN2

Rabea Hinkel, Teresa Trenkwalder, Björn Petersen, Wira Husada, Florian Gesenhues, Seungmin Lee, Ewald Hannappel, Ildiko Bock-Marquette, Daniel Theisen, Laura Leitner, Peter Boekstegers, Czeslaw Cierniewski, Oliver J. Müller, Ferdinand Le Noble, Ralf H. Adams, Christine Weinl, Alfred Nordheim, Bruno Reichart, Christian Weber, Eric OlsonGuido Posern, Elisabeth Deindl, Heiner Niemann, Christian Kupatt

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Gradual occlusion of coronary arteries may result in reversible loss of cardiomyocyte function (hibernating myocardium), which is amenable to therapeutic neovascularization. The role of myocardin-related transcription factors (MRTFs) co-activating serum response factor (SRF) in this process is largely unknown. Here we show that forced MRTF-A expression induces CCN1 and CCN2 to promote capillary proliferation and pericyte recruitment, respectively. We demonstrate that, upon G-actin binding, thymosin ß4 (Tß4), induces MRTF translocation to the nucleus, SRF-activation and CCN1/2 transcription. In a murine ischaemic hindlimb model, MRTF-A or Tß4 promotes neovascularization, whereas loss of MRTF-A/B or CCN1-function abrogates the Tß4 effect. We further show that, in ischaemic rabbit hindlimbs, MRTF-A as well as Tß4 induce functional neovascularization, and that this process is inhibited by angiopoietin-2, which antagonizes pericyte recruitment. Moreover, MRTF-A improves contractile function of chronic hibernating myocardium of pigs to a level comparable to that of transgenic pigs overexpressing Tß4 (Tß4tg). We conclude that MRTF-A promotes microvessel growth (via CCN1) and maturation (via CCN2), thereby enabling functional improvement of ischaemic muscle tissue.

Original languageEnglish (US)
Article number3970
JournalNature Communications
Volume5
DOIs
StatePublished - Jun 9 2014

Fingerprint

vessels
Thymosin
Transcription Factors
Growth
angiogenesis
Serum Response Factor
Pericytes
Hindlimb
myocardium
swine
Myocardium
Swine
serums
Activating Transcription Factors
Angiopoietin-2
myocardin
Transcription
Microvessels
Cardiac Myocytes
occlusion

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Chemistry(all)
  • Physics and Astronomy(all)

Cite this

Hinkel, R., Trenkwalder, T., Petersen, B., Husada, W., Gesenhues, F., Lee, S., ... Kupatt, C. (2014). MRTF-A controls vessel growth and maturation by increasing the expression of CCN1 and CCN2. Nature Communications, 5, [3970]. https://doi.org/10.1038/ncomms4970

MRTF-A controls vessel growth and maturation by increasing the expression of CCN1 and CCN2. / Hinkel, Rabea; Trenkwalder, Teresa; Petersen, Björn; Husada, Wira; Gesenhues, Florian; Lee, Seungmin; Hannappel, Ewald; Bock-Marquette, Ildiko; Theisen, Daniel; Leitner, Laura; Boekstegers, Peter; Cierniewski, Czeslaw; Müller, Oliver J.; Le Noble, Ferdinand; Adams, Ralf H.; Weinl, Christine; Nordheim, Alfred; Reichart, Bruno; Weber, Christian; Olson, Eric; Posern, Guido; Deindl, Elisabeth; Niemann, Heiner; Kupatt, Christian.

In: Nature Communications, Vol. 5, 3970, 09.06.2014.

Research output: Contribution to journalArticle

Hinkel, R, Trenkwalder, T, Petersen, B, Husada, W, Gesenhues, F, Lee, S, Hannappel, E, Bock-Marquette, I, Theisen, D, Leitner, L, Boekstegers, P, Cierniewski, C, Müller, OJ, Le Noble, F, Adams, RH, Weinl, C, Nordheim, A, Reichart, B, Weber, C, Olson, E, Posern, G, Deindl, E, Niemann, H & Kupatt, C 2014, 'MRTF-A controls vessel growth and maturation by increasing the expression of CCN1 and CCN2', Nature Communications, vol. 5, 3970. https://doi.org/10.1038/ncomms4970
Hinkel R, Trenkwalder T, Petersen B, Husada W, Gesenhues F, Lee S et al. MRTF-A controls vessel growth and maturation by increasing the expression of CCN1 and CCN2. Nature Communications. 2014 Jun 9;5. 3970. https://doi.org/10.1038/ncomms4970
Hinkel, Rabea ; Trenkwalder, Teresa ; Petersen, Björn ; Husada, Wira ; Gesenhues, Florian ; Lee, Seungmin ; Hannappel, Ewald ; Bock-Marquette, Ildiko ; Theisen, Daniel ; Leitner, Laura ; Boekstegers, Peter ; Cierniewski, Czeslaw ; Müller, Oliver J. ; Le Noble, Ferdinand ; Adams, Ralf H. ; Weinl, Christine ; Nordheim, Alfred ; Reichart, Bruno ; Weber, Christian ; Olson, Eric ; Posern, Guido ; Deindl, Elisabeth ; Niemann, Heiner ; Kupatt, Christian. / MRTF-A controls vessel growth and maturation by increasing the expression of CCN1 and CCN2. In: Nature Communications. 2014 ; Vol. 5.
@article{a2ea9dc5d526486585305bbb7887f45d,
title = "MRTF-A controls vessel growth and maturation by increasing the expression of CCN1 and CCN2",
abstract = "Gradual occlusion of coronary arteries may result in reversible loss of cardiomyocyte function (hibernating myocardium), which is amenable to therapeutic neovascularization. The role of myocardin-related transcription factors (MRTFs) co-activating serum response factor (SRF) in this process is largely unknown. Here we show that forced MRTF-A expression induces CCN1 and CCN2 to promote capillary proliferation and pericyte recruitment, respectively. We demonstrate that, upon G-actin binding, thymosin {\ss}4 (T{\ss}4), induces MRTF translocation to the nucleus, SRF-activation and CCN1/2 transcription. In a murine ischaemic hindlimb model, MRTF-A or T{\ss}4 promotes neovascularization, whereas loss of MRTF-A/B or CCN1-function abrogates the T{\ss}4 effect. We further show that, in ischaemic rabbit hindlimbs, MRTF-A as well as T{\ss}4 induce functional neovascularization, and that this process is inhibited by angiopoietin-2, which antagonizes pericyte recruitment. Moreover, MRTF-A improves contractile function of chronic hibernating myocardium of pigs to a level comparable to that of transgenic pigs overexpressing T{\ss}4 (T{\ss}4tg). We conclude that MRTF-A promotes microvessel growth (via CCN1) and maturation (via CCN2), thereby enabling functional improvement of ischaemic muscle tissue.",
author = "Rabea Hinkel and Teresa Trenkwalder and Bj{\"o}rn Petersen and Wira Husada and Florian Gesenhues and Seungmin Lee and Ewald Hannappel and Ildiko Bock-Marquette and Daniel Theisen and Laura Leitner and Peter Boekstegers and Czeslaw Cierniewski and M{\"u}ller, {Oliver J.} and {Le Noble}, Ferdinand and Adams, {Ralf H.} and Christine Weinl and Alfred Nordheim and Bruno Reichart and Christian Weber and Eric Olson and Guido Posern and Elisabeth Deindl and Heiner Niemann and Christian Kupatt",
year = "2014",
month = "6",
day = "9",
doi = "10.1038/ncomms4970",
language = "English (US)",
volume = "5",
journal = "Nature Communications",
issn = "2041-1723",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - MRTF-A controls vessel growth and maturation by increasing the expression of CCN1 and CCN2

AU - Hinkel, Rabea

AU - Trenkwalder, Teresa

AU - Petersen, Björn

AU - Husada, Wira

AU - Gesenhues, Florian

AU - Lee, Seungmin

AU - Hannappel, Ewald

AU - Bock-Marquette, Ildiko

AU - Theisen, Daniel

AU - Leitner, Laura

AU - Boekstegers, Peter

AU - Cierniewski, Czeslaw

AU - Müller, Oliver J.

AU - Le Noble, Ferdinand

AU - Adams, Ralf H.

AU - Weinl, Christine

AU - Nordheim, Alfred

AU - Reichart, Bruno

AU - Weber, Christian

AU - Olson, Eric

AU - Posern, Guido

AU - Deindl, Elisabeth

AU - Niemann, Heiner

AU - Kupatt, Christian

PY - 2014/6/9

Y1 - 2014/6/9

N2 - Gradual occlusion of coronary arteries may result in reversible loss of cardiomyocyte function (hibernating myocardium), which is amenable to therapeutic neovascularization. The role of myocardin-related transcription factors (MRTFs) co-activating serum response factor (SRF) in this process is largely unknown. Here we show that forced MRTF-A expression induces CCN1 and CCN2 to promote capillary proliferation and pericyte recruitment, respectively. We demonstrate that, upon G-actin binding, thymosin ß4 (Tß4), induces MRTF translocation to the nucleus, SRF-activation and CCN1/2 transcription. In a murine ischaemic hindlimb model, MRTF-A or Tß4 promotes neovascularization, whereas loss of MRTF-A/B or CCN1-function abrogates the Tß4 effect. We further show that, in ischaemic rabbit hindlimbs, MRTF-A as well as Tß4 induce functional neovascularization, and that this process is inhibited by angiopoietin-2, which antagonizes pericyte recruitment. Moreover, MRTF-A improves contractile function of chronic hibernating myocardium of pigs to a level comparable to that of transgenic pigs overexpressing Tß4 (Tß4tg). We conclude that MRTF-A promotes microvessel growth (via CCN1) and maturation (via CCN2), thereby enabling functional improvement of ischaemic muscle tissue.

AB - Gradual occlusion of coronary arteries may result in reversible loss of cardiomyocyte function (hibernating myocardium), which is amenable to therapeutic neovascularization. The role of myocardin-related transcription factors (MRTFs) co-activating serum response factor (SRF) in this process is largely unknown. Here we show that forced MRTF-A expression induces CCN1 and CCN2 to promote capillary proliferation and pericyte recruitment, respectively. We demonstrate that, upon G-actin binding, thymosin ß4 (Tß4), induces MRTF translocation to the nucleus, SRF-activation and CCN1/2 transcription. In a murine ischaemic hindlimb model, MRTF-A or Tß4 promotes neovascularization, whereas loss of MRTF-A/B or CCN1-function abrogates the Tß4 effect. We further show that, in ischaemic rabbit hindlimbs, MRTF-A as well as Tß4 induce functional neovascularization, and that this process is inhibited by angiopoietin-2, which antagonizes pericyte recruitment. Moreover, MRTF-A improves contractile function of chronic hibernating myocardium of pigs to a level comparable to that of transgenic pigs overexpressing Tß4 (Tß4tg). We conclude that MRTF-A promotes microvessel growth (via CCN1) and maturation (via CCN2), thereby enabling functional improvement of ischaemic muscle tissue.

UR - http://www.scopus.com/inward/record.url?scp=84902248750&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902248750&partnerID=8YFLogxK

U2 - 10.1038/ncomms4970

DO - 10.1038/ncomms4970

M3 - Article

C2 - 24910328

AN - SCOPUS:84902248750

VL - 5

JO - Nature Communications

JF - Nature Communications

SN - 2041-1723

M1 - 3970

ER -